Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016

Background: Xpert® MTB/RIF, a rapid tuberculosis (TB) molecular test, was endorsed by the World Health Organization in 2010. Since then, 34.4 million cartridges have been procured under concessional pricing. Although the roll out of this diagnostic is promising, previous studies showed low market pe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Gates Open Res
Prif Awduron: Cazabon, Danielle, Pande, Tripti, Kik, Sandra, Van Gemert, Wayne, Sohn, Hojoon, Denkinger, Claudia, Qin, Zhi Zhen, Waning, Brenda, Pai, Madhukar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: F1000 Research Limited 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6139378/
https://ncbi.nlm.nih.gov/pubmed/30234198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/gatesopenres.12842.2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg